| Health +Pengyao brand reishi shell... +Pengyao brand yinling capsule Drug +West patent medicines +Chinese traditional medicine +For external use +Bility medicines +Investment Products |
| Jiangsu Pengyao Pharmaceuticals Inc.is the leading comprehensive pharmaceutical enterprise in Yixing City. With registered capitals of 1.62 million US dollars, more than 200 employees,among whom are 100 medium and senior technicians, five master candiates and one doctor candidate and we have a group of skilled, highly-qualified and professional managerial team. The company has more than 200 specifications of product groups in the fields of antibiotics, digestive system drugs, circulatory system drugs, anti-tumor drugs, antipyretic analgesics, health care products, etc., and nearly 90 products have entered the new version of the national essential drug catalog. The main dosage forms are tablet, capsule, solution, pill, suspension, dropping pill, soft capsule, API, etc. The company's main products are calamine lotion, carbamazepine tablets, amlodipine besylate tablets, shark liver alcohol tablets, omeprazole enteric coated capsules, etc. the products sell well in Beijing, Tianjin, Jiangsu, Guangdong, Hunan, Hubei, Shandong, Anhui, Shaanxi and other provinces, cities and districts, and have established a good reputation and customer base in the industry. Based on the existing product technology, the company will enhance the development of follow-up new products and gradually become the main force in the field of comprehensive professional preparations. At present, the company has formed a production scale of 5 billion tablets / year, 500 million capsules / year, 50 million bags / year of traditional Chinese medicine pills, 10 million bottles / year of external medicine, 200 million soft capsules / year and 500 kg drop pills / year. After the implementation of the second phase project under construction, it is estimated that the new production capacity of the company will be 2.5 billion tablets / year, 250 million capsules / year, 100 million small volume injections / year, 50 million bags of traditional Chinese medicine pills (front extraction), 6 million sets of catheters / year and 4 million sets of catheters / year, which will greatly increase the company's production capacity, expand the enterprise's product line and enhance the enterprise's market competitiveness. Pengyao new drug innovation center was established in 2020, which will face the new needs of social development and the new situation of aging society. The center will run through the health culture of Chinese and Western medicine, integrate the scientific health concept of Chinese and Western medicine, carry out the research, development and application of traditional Chinese medicine, chemical medicine, biological medicine, special medical food and health care products, learn social health theory, and improve social health services. On the basis of introduction and self research, gradually form their own advantages in geriatric diseases, metabolic regulation, neuropsychiatric, anti infection, rare diseases, anti-tumor and other fields, establish corresponding workstations, cultivate and reserve leading talents for the subsequent development, build a health industry base, and make due contributions to promoting China's new drugs and health industry. The company adheres to the corporate philosophy of "quality first, the pursuit of human health", carries forward the corporate spirit of "morality, diligence and strength", and adheres to the business tenet of "creating brand with quality, survival with integrity, efficiency with management and development with technology". For many years, the company has been rated as a high-tech enterprise and a trustworthy enterprise in Jiangsu Province.   |